Sidley and Willkie Farr & Gallagher have advised Armis Security; Freshfields has advised ServiceNow. Armis Security, a leading asset intelligence cybersecurity firm, has entered into a...
ServiceNow Acquires Armis Security for US$7.75 Billion in Landmark Cybersecurity Deal
Evotec Sells Just – Evotec Biologics EU and Related Technology Licence to Sandoz
Freshfields has advised Evotec SE. Linklaters has advised Sandoz AG. Evotec SE has entered into an agreement for the sale of its French subsidiary, Just –...
AST SpaceMobile’s $460 Million Convertible Notes Offering
Freshfields advised AST SpaceMobile, Inc. on the offering. AST SpaceMobile, Inc. (“AST SpaceMobile”) announced its offering of $460 million aggregate principal amount of 4.25% Convertible Senior...
OSN’s Acquisition of a Control Stake in Anghami
Freshfields advised OSN on its acquisition of a control stake in Nasdaq-listed Anghami, Inc. In a significant development in the media and entertainment industry, Panther Media...
Boxed, Inc.’s Chapter 11 Filing
Freshfields represented Boxed, Inc. Boxed Inc (BOXD.N) filed for Chapter 11 bankruptcy protection and was pursuing sale of its software business, the e-commerce grocery platform said...
TRM Labs’ $70 Million Series B Financing Expansion
Freshfields represented TRM Labs on the deal. TRM Labs in its announced $70 million expansion of its Series B financing led by Thoma Bravo, resulting in...
Southport Acquisition Corporation’s $230 Million Initial Public Offering
Freshfields advised BofA Securities on the deal. BofA Securities acted as the sole underwriter, on the initial public offering of 23,000,000 units of Southport Acquisition Corporation on...
TRM Labs’ $60 Million Series B Financing
Freshfields represented TRM Labs in the transaction. TRM Labs, a San Francisco-based blockchain intelligence platform, announced a $60 million Series B financing led by Tiger Global,...
Gyroscope Therapeutics’ $148.0 Million Series C Equity Financing
Davis Polk advised Gyroscope Therapeutics Limited on the deal. Gyroscope Therapeutics Limited executed its $148 million private placement of Series C preferred shares. The financing was...